Literature DB >> 19498108

IRAP identifies an endosomal compartment required for MHC class I cross-presentation.

Loredana Saveanu1, Oliver Carroll, Mirjana Weimershaus, Pierre Guermonprez, Elke Firat, Vivian Lindo, Fiona Greer, Jean Davoust, Roland Kratzer, Susanna R Keller, Gabriele Niedermann, Peter van Endert.   

Abstract

Major histocompatibility complex (MHC) class I molecules present peptides, produced through cytosolic proteasomal degradation of cellular proteins, to cytotoxic T lymphocytes. In dendritic cells, the peptides can also be derived from internalized antigens through a process known as cross-presentation. The cellular compartments involved in cross-presentation remain poorly defined. We found a role for peptide trimming by insulin-regulated aminopeptidase (IRAP) in cross-presentation. In human dendritic cells, IRAP was localized to a Rab14+ endosomal storage compartment in which it interacted with MHC class I molecules. IRAP deficiency compromised cross-presentation in vitro and in vivo but did not affect endogenous presentation. We propose the existence of two pathways for proteasome-dependent cross-presentation in which final peptide trimming involves IRAP in endosomes and involves the related aminopeptidases in the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498108     DOI: 10.1126/science.1172845

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  99 in total

Review 1.  MHC presentation via autophagy and how viruses escape from it.

Authors:  Monique Gannage; Christian Münz
Journal:  Semin Immunopathol       Date:  2010-09-21       Impact factor: 9.623

Review 2.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 3.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

4.  Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Athanasios Stamogiannos; Athanasios Papakyriakou; Francois-Xavier Mauvais; Peter van Endert; Efstratios Stratikos
Journal:  ACS Med Chem Lett       Date:  2016-05-31       Impact factor: 4.345

Review 5.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

6.  A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy.

Authors:  Jonas J W Kuiper; Jessica Van Setten; Stephan Ripke; Ruben Van 'T Slot; Flip Mulder; Tom Missotten; G Seerp Baarsma; Laurent C Francioli; Sara L Pulit; Carolien G F De Kovel; Ninette Ten Dam-Van Loon; Anneke I Den Hollander; Paulien Huis in het Veld; Carel B Hoyng; Miguel Cordero-Coma; Javier Martín; Victor Llorenç; Bharti Arya; Dhanes Thomas; Steven C Bakker; Roel A Ophoff; Aniki Rothova; Paul I W De Bakker; Tuna Mutis; Bobby P C Koeleman
Journal:  Hum Mol Genet       Date:  2014-06-22       Impact factor: 6.150

Review 7.  Providing ligands for MHC class I molecules.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

Review 8.  Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.

Authors:  T W H Flinsenberg; E B Compeer; J J Boelens; M Boes
Journal:  Clin Exp Immunol       Date:  2011-05-11       Impact factor: 4.330

Review 9.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

10.  Insulin-regulated aminopeptidase is a key regulator of GLUT4 trafficking by controlling the sorting of GLUT4 from endosomes to specialized insulin-regulated vesicles.

Authors:  Ingrid Jordens; Dorothee Molle; Wenyong Xiong; Susanna R Keller; Timothy E McGraw
Journal:  Mol Biol Cell       Date:  2010-04-21       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.